x

Posted 26 August, 2022

Seer, Inc. appointed Omid Farokhzad as new CEO

Nasdaq:SEER appointed new Chief Executive Officer Omid Farokhzad in a 8-K filed on 26 August, 2022.


  In addition, on August 26, 2022, the Board appointed Omid Farokhzad, M.D. to the office of President of the Company, in addition to his current positions as Chief Executive Officer and Chair of the Board, effective as of Mr. Ostadan's resignation.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Seer, Inc.
Health Care/Life Sciences • Medical Equipment/Supplies
Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. Its Proteograph product suite comprises automation instrument and software, which provides workflow to make proteomic profiling. The company was founded by Philip Ma, Robert S. Langer Jr. and Omid C. Farokhzad on March 16, 2017 and is headquartered in Redwood City, CA.
Market Cap
$123M
View Company Details
Seer, Inc. by TradingView
Relevant filing section
ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 


On August 25, 2022, Omead Ostadan resigned from his position as President of Seer, Inc. (the "Company") and from its Board of Directors (the "Board") for personal reasons, each effective as of September 30, 2022. Effective as of September 30, 2022, the Board has reduced its size from ten members to nine members.


The Company and Mr. Ostadan have entered into a Consultant Agreement to provide transition services and for Mr. Ostadan to serve as a senior advisor to the Company on an hourly basis following his resignation (the "Consultant Agreement"). The description of the Consultant Agreement is qualified in its entirety by the actual agreement, which is attached as Exhibit 10.1 to this Current Report on Form 8-K.


In addition, on August 26, 2022, the Board appointed Omid Farokhzad, M.D. to the office of President of the Company, in addition to his current positions as Chief Executive Officer and Chair of the Board, effective as of Mr. Ostadan's resignation.